These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3126756)

  • 1. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
    Forster SM; Osborne LM; Cheingsong-Popov R; Kenny C; Burnell R; Jeffries DJ; Pinching AJ; Harris JR; Weber JN
    AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological markers in HIV infection.
    Lange JM; Goudsmit J; De Wolf F; Coutinho RA; van der Noordaa J
    Ann Med Interne (Paris); 1988; 139(2):80-3. PubMed ID: 3293504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV serological parameters in the prognosis and follow-up assessment of an HIV infection].
    Grob PJ; Joller-Jemelka H; Lüthy R; Täuber M; Ledergerber B; Brühwiler J; Fierz W
    Schweiz Med Wochenschr; 1988 Jan; 118(2):58-64. PubMed ID: 3422761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
    Lange JM; Paul DA; Huisman HG; de Wolf F; van den Berg H; Coutinho RA; Danner SA; van der Noordaa J; Goudsmit J
    Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1459-62. PubMed ID: 3099912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.
    Allain JP; Laurian Y; Paul DA; Verroust F; Leuther M; Gazengel C; Senn D; Larrieu MJ; Bosser C
    N Engl J Med; 1987 Oct; 317(18):1114-21. PubMed ID: 3477695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.
    Lange JM; Paul DA; de Wolf F; Coutinho RA; Goudsmit J
    AIDS; 1987 May; 1(1):15-20. PubMed ID: 3122785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostico-prognostic significance of the analysis of anti-HIV antibodies and viral antigens in acquired immunodeficiency syndrome. Presentation of 2 paradigmatic cases].
    Venturini L; Serpelloni G; Parolin A; Mezzelani P
    G Clin Med; 1989 May; 70(5):353-6. PubMed ID: 2753265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression.
    McDougal JS; Kennedy MS; Nicholson JK; Spira TJ; Jaffe HW; Kaplan JE; Fishbein DB; O'Malley P; Aloisio CH; Black CM
    J Clin Invest; 1987 Aug; 80(2):316-24. PubMed ID: 3497176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnostic profiles of HIV and HIV pathogenesis in vivo.
    Goudsmit J; Lange JM; Smit L; Bakker M; Klaver B; Danner SA; Coutinho RA
    Haematologia (Budap); 1988; 21(2):71-81. PubMed ID: 3166447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
    Resnick L; Shapshak P
    Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
    Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
    Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
    Schüpbach J; Tanner M
    Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.
    Pedersen C; Nielsen CM; Vestergaard BF; Gerstoft J; Krogsgaard K; Nielsen JO
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):567-9. PubMed ID: 3117234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.